BlackRock, Inc. 13D and 13G filings for Charles River Laboratories International, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
3,524,401 6.900% |
-714,096 (-16.85%) |
Filing |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
4,238,497 8.200% |
0 (Unchanged) |
Filing |
| 2024-10-22 3:24 pm Sale |
2024-09-30 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
4,238,497 8.200% |
-956,589 (-18.41%) |
Filing |
| 2024-01-24 2:27 pm Sale |
2023-12-31 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
5,195,086 10.100% |
-23,666 (-0.45%) |
Filing |
| 2023-07-07 4:37 pm Purchase |
2023-06-30 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
5,218,752 10.200% |
237,607 (+4.77%) |
Filing |
| 2023-01-24 1:56 pm Sale |
2022-12-31 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
4,981,145 9.800% |
-98,881 (-1.95%) |
Filing |
| 2022-01-28 1:54 pm Sale |
2021-12-31 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
5,080,026 10.100% |
-289,587 (-5.39%) |
Filing |
| 2021-01-26 6:52 pm Purchase |
2020-12-31 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
5,369,613 10.800% |
28,230 (+0.53%) |
Filing |
| 2020-07-10 10:39 am Purchase |
2020-06-30 | 13G | Charles River Laboratories International, Inc. CRL |
BLACKROCK INC BLK |
5,341,383 10.800% |
847,430 (+18.86%) |
Filing |